The global diagnostic imaging services market size is calculated at USD 564.62 billion in 2025 and is forecasted to reach around USD 932.27 billion by 2034, accelerating at a CAGR of 5.73% from 2025 to 2034. The North America market size surpassed USD 208.27 billion in 2024 and is expanding at a CAGR of 5.86% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Diagnostic Imaging Services Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Diagnostic Imaging Services Market, by Modality Type
8.1.1. X-ray
8.1.1.1. Market Revenue and Forecast
8.1.2. Nuclear Medicine Scans
8.1.2.1. Market Revenue and Forecast
8.1.3. MRI Scans
8.1.3.1. Market Revenue and Forecast
8.1.4. CT Scans
8.1.4.1. Market Revenue and Forecast
8.1.5. Ultrasound
8.1.5.1. Market Revenue and Forecast
9.1. Diagnostic Imaging Services Market, by End Use
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast
9.1.2. Diagnostic Imaging Centers
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Modality
10.1.2. Market Revenue and Forecast, by End Use
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Modality
10.1.3.2. Market Revenue and Forecast, by End Use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Modality
10.1.4.2. Market Revenue and Forecast, by End Use
10.2. Europe
10.2.1. Market Revenue and Forecast, by Modality
10.2.2. Market Revenue and Forecast, by End Use
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Modality
10.2.3.2. Market Revenue and Forecast, by End Use
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Modality
10.2.4.2. Market Revenue and Forecast, by End Use
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Modality
10.2.5.2. Market Revenue and Forecast, by End Use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Modality
10.2.6.2. Market Revenue and Forecast, by End Use
10.3. APAC
10.3.1. Market Revenue and Forecast, by Modality
10.3.2. Market Revenue and Forecast, by End Use
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Modality
10.3.3.2. Market Revenue and Forecast, by End Use
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Modality
10.3.4.2. Market Revenue and Forecast, by End Use
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Modality
10.3.5.2. Market Revenue and Forecast, by End Use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Modality
10.3.6.2. Market Revenue and Forecast, by End Use
10.4. MEA
10.4.1. Market Revenue and Forecast, by Modality
10.4.2. Market Revenue and Forecast, by End Use
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Modality
10.4.3.2. Market Revenue and Forecast, by End Use
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Modality
10.4.4.2. Market Revenue and Forecast, by End Use
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Modality
10.4.5.2. Market Revenue and Forecast, by End Use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Modality
10.4.6.2. Market Revenue and Forecast, by End Use
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Modality
10.5.2. Market Revenue and Forecast, by End Use
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Modality
10.5.3.2. Market Revenue and Forecast, by End Use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Modality
10.5.4.2. Market Revenue and Forecast, by End Use
11.1. Global Diagnostics
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. RadNet, Inc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Alliance Medical
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Center for Diagnostic Imaging, Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Medica Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Novant Health
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Concord Medical Services Holdings Limited
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. InHealth Group
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Sonic Healthcare
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Healthcare Imaging Services Pty Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample